Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin in Women with Mixed Urinary Incontinence
NCT01505439Phase 4Completed
- Start
- Jun 2011
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of solifenacin in mixed urinary incontinence (MUI). Primary endpoint: Changes in the number of urge urinary incontinence episodes per 24 hours at 12 weeks. Started Jun 2011; status: completed.
02
Drugs
solifenacin
03
Conditions
mixed urinary incontinence (MUI)
Beyond the preview
Go deeper on NCT01505439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01505439.